“…There are wide opportunities for protein switch antibody tests: those developed for infectious disease serology could be widened to autoimmune, allergy, and broader immunology applications, ,,,, and those for therapeutic drug monitoring can guide dosing in the ever-growing biologics market. ,,, Small molecule tests have also been developed for drug monitoring, , as well as metabolic , and disease biomarker assays. , Tests for a range of proteins have also been reported, and the scope expands as new biomarkers are discovered. ,,, Human health applications dominate the literature, but the significant opportunities for quantitative on-site tests should be explored in broader sectors. Some protein switch assays have been developed for food standards, agricultural disease monitoring, and veterinary immunology applications, , but there are much wider prospects in these settings and others, including environmental monitoring, illicit drug detection, and sports medicine …”